As Founder and President of Sit At the Equi-Table, I have invented a patented systems to address health inequities, particularly those affecting underserved and minority groups suffering from food allergies. U.S. Patent No. 12,014,421, titled System for Promoting Health Equity in Diverse and Underserved Groups through Multifaceted Financial Investment Design Employing Artificial Intelligence, introduces a novel method that leverages advanced investment models and AI technology to improve healthcare access and outcomes for marginalized communities.

 

The United States Patent and Trademark Office's (“USPTO”) issuance of this patent is significant because it is a recognition of the importance of health equity, especially for underserved and minority groups. The USPTO only issues utility patents if they are novel and useful, and therefore, by granting this patent, the USPTO is acknowledging that our invention is not only novel but also useful. The grant of this patent underscores the urgency and relevance of addressing systemic health disparities, particularly for populations that are often left behind in clinical trials, medical research, and equitable healthcare distribution. This patent highlights a transformative approach, combining financial innovation with AI-driven models that aim to restructure healthcare funding and resource allocation. It is designed to prioritize inclusion, efficiency, and sustainability in the fight for health equity. The system offers the potential to positively impact not only food allergy sufferers but also a broader range of marginalized groups that face barriers in accessing proper healthcare treatments and interventions.

 

U.S. Patent Application No. 18/661,425, titled Diversity, Equity, and Inclusion Artificial Intelligence Training for Mitigating Bias and Improving Financial Investment in Health Equity, further advances our mission by incorporating AI-driven training modules that identify and mitigate implicit biases in financial decision-making for funding health equity.

 

As AI becomes an increasingly influential tool in decision-making across various industries, including healthcare and finance, there is a critical need to ensure that it is harnessed responsibly to address, rather than perpetuate, existing disparities. AI, when left unchecked, can unintentionally reinforce biases due to the data it is trained on, which often reflects historical inequities. This patent application introduces a novel solution by using AI itself to identify and mitigate these biases, ensuring that financial decisions related to healthcare investment are fair, inclusive, and tailored to promote health equity. This is crucial in a time when AI-driven tools are being adopted more broadly, and decisions influenced by AI can have wide-reaching impacts on access to resources and services for underserved populations.

 

By embedding bias-mitigation into AI systems, this patent application ensures that as AI continues to evolve, it does so in a way that actively contributes to the dismantling of systemic barriers in healthcare. This approach aligns with the growing recognition that AI must be part of the solution to promote fairness and justice, particularly in financial investment decisions that can either widen or close gaps in healthcare access for minority and underserved groups. The integration of AI to advance diversity, equity, and inclusion in this context is not just timely but essential for the future of equitable healthcare.

 

These inventions reflect our commitment to finding meaningful, data-driven, financial solutions to promote equity in healthcare and are increasingly crucial as AI becomes a larger part of our health system. Please click the links on our website for these inventions to learn more about them.